Compounds for the treatment and prevention of adhesives, pharmacological components related to the compounds, and methods for the prevention and treatment of adhesives
It refers to p38 MAP quinasa inhibitors, such as 4 - (4-fluorofenil) - 2 - (4-methylsulfuryl) - 5 - (4-pyridyl-1-pyridyl-azole, formula compound (I),R1 is the structural unit of soluble polymer in natural or synthetic basic water, such as kitasan, PVC, polyethylene, etc.； the integers of X and y are different from 0. He also mentioned a pharmaceutical composer These compounds have anti viscosity activity and can be used for the treatment of precursors in serum membranes, bleeding or associated diseases of Dano.SE REFIERE A COMPUESTOS INHIBIDORES DE LA p38 MAP QUINASA TALES COMO 4-(4-FLUOROFENIL)-2-(4-METILSULFONILFENIL)-5-(4-PIRIDIL)-1H-IMIDAZOL, EL COMPUESTO DE FORMULA (I), ENTRE OTROS, DONDE R1 ES UNA UNIDAD ESTRUCTURAL DE POLIMEROS SOLUBLES EN AGUA DE CARACTER BASICO DE ORIGEN NATURAL O SINTETICO TAL COMO QUITOSANO, POLIVINILTETRAZOL, POLIVINILPIRIDINAS, ENTRE OTROS； x E y SON NUMEROS ENTEROS DIFERENTES DE 0. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACTIVIDAD ANTIADHERENCIA SIENDO UTILES EN EL TRATAMIENTO DE ENFERMEDADES ACOMPANADAS DE EXUDADO, SANGRADO O DANO EN LA MEMBRANA SEROSA
